The Digital Source For China's Tech Innovation Since 2000

Search
Close

Celsion Announces Formation Of Development JV

December 16, 2003
Science

Celsion Corporation today announced that it has established a joint venture to develop its technologies and distribute its products in Greater China with Asia Pacific Life Sciences Group Limited, a group of Hong Kong-based investors.

Celsion is a biotechnology company dedicated to the development and commercialization of treatment systems for cancer and other diseases using focused-heat energy, either administered alone, or in combination with other therapeutic devices, heat activated genes and heat activated drugs.

Dr. Augustine Cheung, Celsion's President and Chief Executive Officer said, "We are excited to have established a presence in China. We believe that the growing healthcare industry and evolving regulatory climate in China currently are very receptive to new technologies for the treatment of cancer and other serious diseases. In this environment, the opportunity for our tumor targeting, heat-activated liposome and gene products for cancer treatment could be significant. Additionally, the Chinese medical community historically has been interested in heat as a therapeutic modality, especially for the treatment of cancer. Over the last several years we have built a network of China-based scientists, clinicians and thought leaders in the field of heat-based therapies who now anticipate a new focus on heat-based treatments in cancer care. Through our joint venture with Asia Pacific Life Sciences Group Limited, we expect to continue the process of demonstrating the efficacy of our technology, which has already produced very promising results in animal studies, in treating a wide variety of cancers and localized infectious and inflammatory diseases.

"In the short term, we expect that the pre-market approval of our Microfocus BPH 800 Microwave Urethroplasty(TM) System will be expedited in China once we receive approval from the FDA to market the system in the United States. Such an approval will enable the rapid roll-out of the system in Greater China and the early generation of revenues."

Tags: ASIA | Asia Pacific | Biotech | China | Chinese | community | development | drugs | energy | environment | executive | Greater China | healthcare | Hong Kong | IT | joint venture | JV | KONG | medical | network | Pacific | president | technology | United States

Other Related News:

Autonomy Begins Joint Venture With China Netcom Broadband

July 18, 2005

TikTok ? Ep141 (TikTok China)

October 30, 2021

Watching China lose to the United States at the Beijing Olympics as my first hockey game, I wasn’t the only one confused in the crowd

February 11, 2022

HTC Reports Net Profit Of NTD2.76 Billion In Q2 2014

July 10, 2014

Ukraine: Turning to cryptocurrencies in an effort to keep funds safe

February 27, 2022

Shanda Reports MMORPG Revenue Jump; Casual Games Decline In China

September 3, 2008

JustInvest LLC Boosts Stake in Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM)

January 8, 2022

China AI in Edge Computing Market Report 2021 – Prospects, Trends Analysis, Market Size and Forecasts up to 2026

August 25, 2021

Apple states that it is its responsibility to work in China too, despite the country being boycotted by Human Rights Advocates

November 13, 2021
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
Menu
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
© 2022 ChinaTechNews.com. A Service of Asia Media Network.
Twitter
Posting....